[1]Marra F,Marra CA,Bruchet N,Richardson K,Moadebi S,Elwood RK,FitzGerald JM.Adverse drug reactions associated with first-line anti-tuberculosis drug regimens[J].Int J Tuberc Lung Dis,2007,11(8):868-875.[2] Cain KP, Kanara N, Laserson KF, Vannarith C, Sameourn K, Samnang K, Qualls ML,Wells CD, Varma JK. The epidemiology of HIV-associated tuberculosis in rural Cambodia[J]. Int J Tuberc Lung Dis. 2007, 11(9):1008-1013.[3] 杨年忠,王金花,郑丽君.321例肺结核抗结核组合药不良反应临床监测[J].中国医院药学杂志,2007,27(1):83-84.[4] 谢莉,高微微,卜建玲,马玙.702例抗结核药物所致不良反应分析[J].中国防痨杂志,2008,30(4):275-278.[5] 夏愔愔,詹思延.国内抗结核药不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423.[6] Kevin P.Cain,Thanomsak Anekthananon,Channawong Burapat,Somsak Akksilp,Wiroj Mankhatitham,Chawin Srinak,Sriprapa Nateniyom,Wanchai Sattayawuthipong,Theerawit Tasaneeyapan, Jay K.Varma. Causes of death in HIV-infected persons who have tuberculosis,Thailand[J].Emerging Infectious Diseases“ www.cdc.gov/eid”,2009,15(2):258-264.[7] 卫生部艾滋病临床专家工作组. 国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2007,40.[8] 张晓燕.艾滋病研究最新进展[J].中国艾滋病性病,2007,13(5): 502-504.[9] 袁静, 余卫业, 胡毅文, 蒋小玲, 骆子义, 文彬, 刘艳, 邬明.23例艾滋病合并结核病患者的临床特点[J].中华结核和呼吸杂志,2004,27(11):767-770. [10]宋传锋,傅继华,刘学真,康殿民,陶小润,李令国,霍炜,井文喜. 艾滋病患者抗病毒治疗最佳时机探讨[J].山东医药,2009, 49(19):50-51. |